Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Rezolute, Inc.RZLT · Entity 1990 | Chief Medical Officer | July 02, 2026 | July 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Rezolute, Inc.
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 293,851 |
Reported balance
After 2026-07-02 transaction · row 1
1 source rowRow 1 · 2026-07-02 · Tax withholding · Disposed 3,062 · Balance 293,851 F1: The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |
| Common SharesSEC Table I · non-derivative | IndirectHeld in IRA | 15,500 |
Reported balance
Holding disclosure · report date 2026-07-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,500 |
Filing footnotes · ownership attribution and instrument terms
F1: The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2026 Filed Jul 7, 2026 22:36 UTC | Rezolute, Inc. RZLT · Entity 1990 | Tax withholdingCommon Shares | 3,062 | $4.99 | $15,279.38 |
DisclosureSEC source: 0000912282-26-000936 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,851 F1 · kind: The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:18 UTC | Rezolute, Inc. RZLT · Entity 1990 | Tax withholdingCommon Shares | 11,439 | $2.99 | $34,202.61 |
DisclosureSEC source: 0000912282-26-000412 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,913 F1 · kind: The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The sale price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.07 inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:13 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 28,000 | $1.70 | $47,600.00 |
DisclosureSEC source: 0000912282-25-001427 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,352 Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 22:53 UTC | Rezolute, Inc. RZLT · Entity 1990 | OtherEmployee Stock Option (Right to Buy) · Derivative | 72,000 | $0.00 Strike: $10.16 | $0.00 |
DisclosureSEC source: 0000912282-25-001299 · form4.xml · derivative · entry 3 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Shares · 72,000 shares Expires 2035-11-19 F2 · derivative.exercise_date: The options vest 1/36th monthly beginning on December 19, 2025. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 22:53 UTC | Rezolute, Inc. RZLT · Entity 1990 | GrantCommon Shares | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001299 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,352 F1 · shares: Represents grant of restricted stock units which vest annually over a three-year period with the first RSUs vesting on December 1, 2026. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 13:07 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 2,500 | $4.38 | $10,939.00 |
DisclosureSEC source: 0000912282-25-000718 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,500 F1 · price: The purchaes price reported above is a weight average price. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.38, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 10, 2025 Filed Jun 13, 2025 01:19 UTC | Rezolute, Inc. RZLT · Entity 1990 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0000912282-25-000659 · form4.xml · derivative · entry 4 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Shares · 15,000 shares Expires 2035-06-10 F2 · derivative.exercise_date: The options vest as follows: 1/36th monthly beginning on July 10, 2025. Read SEC document |
| June 10, 2025 Filed Jun 13, 2025 01:19 UTC | Rezolute, Inc. RZLT · Entity 1990 | GrantCommon Shares | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000659 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,352 F1 · shares: Represents grant of restricted stock units which vest as follows: 1/3 on July 1, 2026; 1/3 on July 1, 2027; and 1/3 on July 1, 2028. Read SEC document |
| February 16, 2025 Filed Feb 20, 2025 01:58 UTC | Rezolute, Inc. RZLT · Entity 1990 | GrantEmployee Stock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $4.61 | $0.00 |
DisclosureSEC source: 0000912282-25-000173 · form4.xml · derivative · entry 4 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Shares · 45,000 shares Expires 2035-02-16 F2 · derivative.exercise_date: The options vest as follows: 1/36th monthly beginning on March 16, 2025. Read SEC document |
| February 16, 2025 Filed Feb 20, 2025 01:58 UTC | Rezolute, Inc. RZLT · Entity 1990 | GrantCommon Shares | 77,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000173 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,352 F1 · shares: Represents grant of restricted stock units which vest as follows: 1/3 on March 1, 2026; 1/3 on March 1, 2027; and 1/3 on March 1, 2028. Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 16:51 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 300 | $3.97 | $1,190.97 |
DisclosureSEC source: 0000912282-24-000496 · form4.xml · nonDerivative · entry 4 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by minor child Disclosed balance after: 1,376 Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 16:51 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 3,000 | $3.91 | $11,724.60 |
DisclosureSEC source: 0000912282-24-000496 · form4.xml · nonDerivative · entry 3 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held in IRA Disclosed balance after: 13,000 Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 16:51 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 300 | $3.96 | $1,188.00 |
DisclosureSEC source: 0000912282-24-000496 · form4.xml · nonDerivative · entry 2 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,352 Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 16:51 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 4,000 | $3.91 | $15,639.60 |
DisclosureSEC source: 0000912282-24-000496 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,052 Read SEC document |
| May 23, 2024 Filed May 28, 2024 18:56 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 6,000 | $2.68 | $16,057.80 |
DisclosureSEC source: 0000912282-24-000461 · form4.xml · nonDerivative · entry 2 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,052 Read SEC document |
| May 23, 2024 Filed May 28, 2024 18:56 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 1,500 | $2.72 | $4,080.00 |
DisclosureSEC source: 0000912282-24-000461 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,052 Read SEC document |
| March 28, 2024 Filed Mar 29, 2024 15:08 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 500 | $2.55 | $1,275.00 |
DisclosureSEC source: 0000912282-24-000331 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by minor child Disclosed balance after: 1,076 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 15:20 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 10,000 | $1.88 | $18,800.00 |
DisclosureSEC source: 0000912282-24-000270 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held in IRA Disclosed balance after: 10,000 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 500 | $1.85 | $925.00 |
DisclosureSEC source: 0000912282-24-000236 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by minor child Disclosed balance after: 500 Read SEC document |
| March 07, 2024 Filed Mar 18, 2024 15:19 UTC Amendment | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 500 | $1.85 | $925.00 |
DisclosureSEC source: 0000912282-24-000268 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by minor child Disclosed balance after: 576 Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 13:47 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 2,000 | $1.70 | $3,400.00 |
DisclosureSEC source: 0000912282-24-000187 · form4.xml · nonDerivative · entry 2 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,552 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 13:47 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 6,000 | $1.69 | $10,140.00 |
DisclosureSEC source: 0000912282-24-000187 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,552 F1 · price: The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.6985, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 16:55 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 7,000 | $1.31 | $9,142.00 |
DisclosureSEC source: 0000912282-24-000172 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,552 F1 · price: The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.320, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 17:36 UTC | Rezolute, Inc. RZLT · Entity 1990 | GrantEmployee Stock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0000912282-24-000085 · form4.xml · derivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Shares · 130,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The options vest in 36 equal monthly installments, beginning February 23, 2024. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 15:18 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Shares | 5,000 | $1.90 | $9,499.50 |
DisclosureSEC source: 0000912282-23-000162 · form4.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,552 Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 22:12 UTC | Rezolute, Inc. RZLT · Entity 1990 | GrantStock Option (right to buy) · Derivative | 700,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001567619-22-013416 · doc1.xml · derivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Sr VP, Clinic Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2032-06-23 F1 · derivative.exercise_date: This Option shall vest and become exercisable as follows: one fourth (1/4) of such Options shall vest on the one year anniversary of the Grant date and one thirty-sixth (1/36) of the remaining Options shall vest on the same day of each month thereafter until the Option is 100% vested. The unvested portion of the Option will not be exercisable on or after the Reporting Person's termination of Continuous Service. Read SEC document |
| May 19, 2022 Filed May 19, 2022 19:13 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Stock | 300 | $2.95 | $883.77 |
DisclosureSEC source: 0001567619-22-011253 · doc1.xml · nonDerivative · entry 3 ROBERTS BRIAN KENNETH · CIK 0001829608 · Sr VP, Clinic Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,552 Read SEC document |
| May 18, 2022 Filed May 19, 2022 19:13 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Stock | 200 | $2.86 | $571.98 |
DisclosureSEC source: 0001567619-22-011253 · doc1.xml · nonDerivative · entry 2 ROBERTS BRIAN KENNETH · CIK 0001829608 · Sr VP, Clinic Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,252 Read SEC document |
| May 17, 2022 Filed May 19, 2022 19:13 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Stock | 1,000 | $3.41 | $3,406.50 |
DisclosureSEC source: 0001567619-22-011253 · doc1.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Sr VP, Clinic Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,052 Read SEC document |
| May 04, 2022 Filed May 6, 2022 21:18 UTC | Rezolute, Inc. RZLT · Entity 1990 | PurchaseCommon Stock | 21,052 | $3.80 | $79,997.60 |
DisclosureSEC source: 0001567619-22-009701 · doc1.xml · nonDerivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Sr VP, Clinic Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,052 F1 · kind: The Reporting Person acquired these shares of common stock in connection with the Issuer's closing of registered direct public offering on May 4, 2022. Read SEC document |
| June 14, 2021 Filed Jul 15, 2021 01:00 UTC | Rezolute, Inc. RZLT · Entity 1990 | Disposition to issuerStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $14.50 | $0.00 |
DisclosureSEC source: 0001567619-21-013435 · doc1.xml · derivative · entry 3 ROBERTS BRIAN KENNETH · CIK 0001829608 · Sr VP, Clinic Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2029-07-31 F2 · derivative.exercise_date: The disposed of options only vest equally over a 36-month period following certain performance and market price criteria, which had not been met through date of disposition. Read SEC document |
| June 14, 2021 Filed Jul 15, 2021 01:00 UTC | Rezolute, Inc. RZLT · Entity 1990 | Disposition to issuerStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $52.50 | $0.00 |
DisclosureSEC source: 0001567619-21-013435 · doc1.xml · derivative · entry 2 ROBERTS BRIAN KENNETH · CIK 0001829608 · Sr VP, Clinic Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9 shares Expires 2027-04-13 Read SEC document |
| June 14, 2021 Filed Jul 15, 2021 01:00 UTC | Rezolute, Inc. RZLT · Entity 1990 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $12.28 | $0.00 |
DisclosureSEC source: 0001567619-21-013435 · doc1.xml · derivative · entry 1 ROBERTS BRIAN KENNETH · CIK 0001829608 · Sr VP, Clinic Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-06-14 F1 · derivative.exercise_date: The Option will become vested and exercisable as follows: (i) 25% of options shall vest on Grant date and (ii) one thirty-sixth (1/36) of remaining such Options shall vest each month thereafter on the first day of each month until the Option is 100% vested. The unvested portion of the Option will not be exercisable on or after the Reporting Person's termination of Continuous Service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.